Stocks / Finance · Brokers & investment banks
Uranium Royalty UROY
Outside our quality screen, so we don’t track its dips. It’s 40% below its 52-week high.
Outside our quality screen, 20% under its Market Value. No fair value estimate for now: there isn’t enough data.
- Fair value est.
- n/a
- Market Value
- $4.08price −20%
- Off 52-wk high
- −40%
- Risk vs market
- Highbeta 2.32
52-week range 22% of the way from its 52-week low to its high
Price $3.25Market Value $4.08
5 bullish · 5 bearish See why
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
No estimate for UROY: Capital spending isn't tagged in SEC XBRL data. We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much UROY moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings much more than the market, and its own price swings are 5.3× the S&P 500’s.
- Beta vs S&P 500
- 2.32
- Volatility
- 67% vs 13% SPY
- Correlation SPY
- 0.44
- Correlation QQQ
- 0.45
Valuation details
MV $4.08
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 5 of 5
GrowthSales compounded 145% a year from FY2024 to FY2026.
ProfitabilityOperating margin widened to 25.9% in FY2026 from 16.3% in FY2024 (SEC filings).
Balance sheetOperating income covers interest 125× over.
ValuationPrice / book of 1.2×, below the 1.6× median for the 368 Finance companies we cover.
ValuationTrades 20.3% below its Market Value of $4.08, the average price paid since the Sep 15 filing.
Top bearish points 5 of 5
Cash returnsShare count up 17.7% in a year: existing holders are being diluted.
Balance sheetNet debt of $539M, 45% of the market cap (Jul 31, 2026).
ProfitabilityReturn on invested capital of 3%, below the 9.5% discount rate our DCF uses.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%.
RiskSwings hard: beta 2.32 vs the S&P 500 and 67% yearly volatility (SPY 13%).
All fundamentals
P/E 21.6 · ROE 6%
Valuation
- P/E
- 21.6×Finance median 13.3×
- Price / FCF
- n/anot reported in its SEC filings
- FCF yield
- n/anot reported in its SEC filings
- EV / EBITDA
- 27.7×
- Price / sales
- 5.62×
- Price / book
- 1.25×
- Market cap
- $1.2Blisted
- Enterprise value
- $1.7B
Growth
- Revenue, 12 months
- $214M
- Sales growth, 12 months
- n/ano year-ago 12-month revenue
- Sales growth, 3 yrs
- +144.7%/yrfrom FY2024
- Diluted EPS, 12 months
- $0.38
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- $55M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- n/agross profit isn't reported (common for service and financial companies)
- Operating margin
- 29.3%
- Net margin
- 26.0%
- FCF margin
- n/anot reported in its SEC filings
- Return on equity
- 6%
- Return on invested capital
- 3%
Balance sheet
- Cash & short-term inv.
- $54M
- Total debt
- $593M
- Net cash
- −$539M
- Debt / equity
- 0.62×
- Interest coverage
- 125.2×operating income / interest
Cash flow & returns
- Free cash flow, 12 months
- n/anot reported in its SEC filings
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 0%
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +17.7%diluted shares vs a year ago
- Stock-based comp
- $762,000
Trailing 12 months to Jul 31, 2026; balance sheet at Jul 31, 2026. From Uranium Royalty’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.2B · Sales +113%
- Free cash flow, 12 months$0.2B
- Free-cash-flow yield16.7%
- Return on equity8%
- Sales growth (latest quarter vs year-ago quarter)+113%
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $3.25
- 52-wk lowlowest close, 1 year$2.61−19.7%
- PriceMon Nov 2 close$3.25you are here
- Market Valueavg paid since Sep 15$4.08+25.5%
- 52-wk highhighest close, 1 year$5.46+68.0%
Momentum & 52-week range
RSI 34 · 5 days −4.4%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
UROY is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on Uranium Royalty in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 5:14 PM ET.
Compare with peers
Closest in size in Brokers & investment banks
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.